Učitavanje...
The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience
The treatment of persistent asthma has been aided by the recent approval of new medications. The combined inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) powder inhaler fluticasone furoate (FF)/vilanterol trifenatate (VI) is one of these new agents, which was recently approved as a mainte...
Spremljeno u:
| Izdano u: | Ther Adv Respir Dis |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933662/ https://ncbi.nlm.nih.gov/pubmed/26668137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815619136 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|